Ohmx Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$7M
- Investors
-
7
Ohmx General Information
Description
Developer of a point-of-care monitoring system designed to quantify analytes from low-volume biological samples. The company provides quantitative analysis of DNA, proteins, and small molecules at the POC and the analyzer is a portable blood analyzer that healthcare providers use for screening, diagnosing and monitoring patients, enabling clients to monitor and detect both acute and chronic diseases.
Contact Information
Website
www.ohmxbio.comCorporate Office
- 1801 Maple
- Suite 6143
- Evanston, IL 60201
- United States
Corporate Office
- 1801 Maple
- Suite 6143
- Evanston, IL 60201
- United States
Ohmx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
12. Later Stage VC | 16-Feb-2018 | $7M | Completed | Generating Revenue | ||
11. Accelerator/Incubator | 01-Jan-2015 | Completed | Generating Revenue | |||
10. Grant | 24-Sep-2014 | Completed | Generating Revenue | |||
9. Accelerator/Incubator | 27-Mar-2013 | Completed | Generating Revenue | |||
8. Later Stage VC (Series A) | 10-Oct-2012 | Completed | Generating Revenue | |||
7. Early Stage VC (Series A) | 26-Dec-2010 | Completed | Startup | |||
6. Grant | 27-Sep-2010 | Completed | Startup | |||
5. Early Stage VC (Series A) | 28-Feb-2008 | Completed | Startup | |||
4. Grant | 15-Mar-2006 | $175K | $3.2M | Completed | Startup | |
3. Early Stage VC (Series A) | 13-Feb-2006 | $2.1M | $3.2M | Completed | Startup |
Ohmx Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A |
Ohmx Patents
Ohmx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20160178562-A1 | Competitive enzymatic assay | Inactive | 19-Dec-2014 | ||
US-20160097082-A1 | Prostate specific antigen proteolytic activity for clinical use | Inactive | 23-Sep-2014 | ||
US-20160041118-A1 | Enzyme triggered redox altering chemical elimination (e-trace) assay with multiplexing capabilities | Inactive | 11-Aug-2014 | ||
US-20150323484-A1 | Bioelectronic binding assay using peak profiling | Active | 29-Apr-2014 | ||
EP-3137904-A1 | Bioelectronic binding assay using peak profiling | Inactive | 29-Apr-2014 | G01N33/5438 |
Ohmx Signals
Ohmx Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Novalis Biotech | Venture Capital | Minority | ||
Garage Incubator | Accelerator/Incubator | Minority | ||
National Cancer Institute | Government | |||
Illinois Finance Authority | Government | Minority | ||
The Illinois Technology Enterprise Center at Northwestern University | University |
Ohmx FAQs
-
When was Ohmx founded?
Ohmx was founded in 2005.
-
Where is Ohmx headquartered?
Ohmx is headquartered in Evanston, IL.
-
What is the size of Ohmx?
Ohmx has 20 total employees.
-
What industry is Ohmx in?
Ohmx’s primary industry is Monitoring Equipment.
-
Is Ohmx a private or public company?
Ohmx is a Private company.
-
What is Ohmx’s current revenue?
The current revenue for Ohmx is
. -
How much funding has Ohmx raised over time?
Ohmx has raised $20.1M.
-
Who are Ohmx’s investors?
Novalis Biotech, Garage Incubator, National Cancer Institute, Illinois Finance Authority, and The Illinois Technology Enterprise Center at Northwestern University are 5 of 7 investors who have invested in Ohmx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »